Changes in tumor antigen peptide specific immune responses Baseline and 24 weeks [clinicaltrials_resource:bdc810588a6232933ee34d279db610ec]

Changes in tumor antigen peptide specific immune responses Baseline and 24 weeks [clinicaltrials_resource:bdc810588a6232933ee34d279db610ec]

Plots of the percent changes in these factors from their pretreatment levels against time will be constructed.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:bdc810588a6232933ee34d279db610ec
Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma [clinicaltrials:NCT00006243]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Changes in tumor antigen peptide specific immune responses Baseline and 24 weeks [clinicaltrials_resource:bdc810588a6232933ee34d279db610ec]

Plots of the percent changes in these factors from their pretreatment levels against time will be constructed.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:bdc810588a6232933ee34d279db610ec
Bio2RDF identifier
bdc810588a6232933ee34d279db610ec
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bdc810588a6232933ee34d279db610ec
measure [clinicaltrials_vocabulary:measure]
Changes in tumor antigen peptide specific immune responses
time frame [clinicaltrials_vocabulary:time-frame]
description
Plots of the percent changes i ...... inst time will be constructed.
identifier
clinicaltrials_resource:bdc810588a6232933ee34d279db610ec
title
Changes in tumor antigen peptide specific immune responses Baseline and 24 weeks
@en
inDataset
type
label
Changes in tumor antigen pepti ...... 810588a6232933ee34d279db610ec]
@en